Quest Diagnostics Announces Board Leadership Changes Daniel C. Stanzione to Retire from Board and as Lead Independent Director Timothy M. Ring Selected New Lead Independent Director Vicky B. Gregg Selected Chair, Compensation Committee
News provided by
Share this article
Share this article
SECAUCUS, N.J., Feb. 23, 2021 /PRNewswire/ Quest Diagnostics Incorporated (NYSE: DGX), the world s leading provider of diagnostic information services, announced changes in the leadership of its Board of Directors. Daniel C. Stanzione, Ph.D., 75, has decided to step down from his role as Lead Independent Director and will not stand for reelection at the annual meeting of stockholders scheduled for May 21, 2021. Dr. Stanzione, President Emeritus of Bell Laboratories, joined the company s Board in 1997, just as the company s stock became publicly-traded. He became the company s first Lead Independent Director in 2003. In 2012, he became non-executive Chairman of the Board, and served
Quest Diagnostics Announces Board Leadership Changes prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
EPB Benefits From Surprising Amount Of New Construction During Pandemic Friday, December 18, 2020 - by Gail Perry At the last EPB board meeting of the year, President and CEO David Wade said the utility benefited from an increase in construction during the pandemic.
The increase in new construction during 2020 was a surprise, he said. There has not been a slowdown during the global pandemic, but a slight increase in building new subdivisions, houses, businesses and apartments. This has resulted in new customers and increased sales for EPB even though there was not an increase in kilowatt hours used because of fairly mild weather and because every year homes and devices are becoming more energy efficient.